Mithramycin targets head and neck cancer stem cells by inhibiting Sp1 and UFMylation
UFMylation is an important process in CSCs, and mithramycin, or its lesser toxic analogs, should be further explored as CSCs targeted therapy in HNSCC.
Authors
- Tea Vasiljević (ORCID: https://orcid.org/0000-0001-7195-6219)
- Tanja Matijević Glavan (ORCID: https://orcid.org/0000-0002-1487-6164)
- Kristina Vuković Đerfi
- Tea Dragičević
Institutions
- Ruđer Bošković Institute (HR)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1186/s12935-024-03609-6
- Citations
- 3
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.70
Funders
- Hrvatska Zaklada za Znanost